Tuesday, November 17, 2026 · Daily editionET --:--:--

Regulator

Medtronic said the FDA cleared Hugo for general surgery, including gallbladder removal and hernia repair.

A regulator's decision · Company-reported · Sets Hugo's stage

What the source says

“Medtronic said Tuesday the Food and Drug Administration has cleared the Hugo robotic system for use in general surgery procedures.”
MedTech Dive, 17 Nov 2026

What it means

Medtronic's claim, if it holds, widens what Hugo can do in the US well beyond urology. It follows the June 2026 request to the FDA for general surgery and gynecologic surgery. The record shows nothing yet on the gynecologic request. Hugo has been at stage 5 since its first US urology clearance, and the first US operation came in February 2026. Rivals such as da Vinci 5 and Dexter also sit at stage 5, so the contest now looks like one of range of uses.

Hugo, from Medtronic, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. This event is one of the milestones that placed it there. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.

Human help: The maker hasn't said whether people help it remotely.

Written with AI from our record of Hugo and checked against it: every figure appears in that record.